

Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version















Insider Trading - Viking Global Opportunities Gp LLC - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Viking Global Opportunities Gp LLC





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-02-08Purchase(A)
2016-02-095:59 pm
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.Other
2,040,814
$0
$0
2,729,808(IndirectDirect)
View


2016-02-08Purchase
2016-02-089:45 pm
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
2,040,814
$0
$0
2,729,808(IndirectDirect)
View




 (A) Indicate amendment filing.
 Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-02-08Conversion
2016-02-095:59 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.Other
1,709,401
$0
2,729,808(Indirect)
View


2016-02-08Conversion
2016-02-095:59 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.Other
1,709,401
$0
2,729,808(Direct)
View


2016-02-08Conversion
2016-02-095:59 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.Other
4,444,444
$0
2,729,808(Indirect)
View


2016-02-08Conversion
2016-02-095:59 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.Other
4,444,444
$0
2,729,808(Direct)
View


2016-02-08Conversion
2016-02-089:45 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
1,709,401
$0
2,729,808(Indirect)
View


2016-02-08Conversion
2016-02-089:45 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
1,709,401
$0
2,729,808(Direct)
View


2016-02-08Conversion
2016-02-089:45 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
4,444,444
$0
2,729,808(Indirect)
View


2016-02-08Conversion
2016-02-089:45 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
4,444,444
$0
2,729,808(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 23:35:39 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  











Insider Trading - Viking Global Investors Lp - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Viking Global Investors Lp





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-02-08Purchase(A)
2016-02-095:59 pm
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.Other
2,040,814
$0
$0
2,729,808(IndirectDirect)
View


2016-02-08Purchase
2016-02-089:45 pm
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
2,040,814
$0
$0
2,729,808(IndirectDirect)
View




 (A) Indicate amendment filing.
 Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-04-13Conversion
2016-04-157:05 pm
N/AN/A
First Data Corp
FDC
Viking Global Investors LpViking Global Performance LLCViking Global Equities LpViking Global Equities II LpVge III Portfolio Ltd.Viking Long Fund Gp LLCViking Long Fund Master Ltd.Halvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
21,750,064
$0
21,750,064(Indirect)
View


2016-04-13Conversion
2016-04-157:05 pm
N/AN/A
First Data Corp
FDC
Viking Global Investors LpViking Global Performance LLCViking Global Equities LpViking Global Equities II LpVge III Portfolio Ltd.Viking Long Fund Gp LLCViking Long Fund Master Ltd.Halvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
5,413,702
$0
21,750,064(Direct)
View


2016-04-13Conversion
2016-04-157:05 pm
N/AN/A
First Data Corp
FDC
Viking Global Investors LpViking Global Performance LLCViking Global Equities LpViking Global Equities II LpVge III Portfolio Ltd.Viking Long Fund Gp LLCViking Long Fund Master Ltd.Halvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
317,519
$0
21,750,064(Direct)
View


2016-04-13Conversion
2016-04-157:05 pm
N/AN/A
First Data Corp
FDC
Viking Global Investors LpViking Global Performance LLCViking Global Equities LpViking Global Equities II LpVge III Portfolio Ltd.Viking Long Fund Gp LLCViking Long Fund Master Ltd.Halvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
10,144,738
$0
21,750,064(Direct)
View


2016-04-13Conversion
2016-04-157:05 pm
N/AN/A
First Data Corp
FDC
Viking Global Investors LpViking Global Performance LLCViking Global Equities LpViking Global Equities II LpVge III Portfolio Ltd.Viking Long Fund Gp LLCViking Long Fund Master Ltd.Halvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
5,874,105
$0
21,750,064(Direct)
View


2016-04-13Conversion
2016-04-157:05 pm
N/AN/A
First Data Corp
FDC
Viking Global Investors LpViking Global Performance LLCViking Global Equities LpViking Global Equities II LpVge III Portfolio Ltd.Viking Long Fund Gp LLCViking Long Fund Master Ltd.Halvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
21,750,064
$0
21,750,064(Indirect)
View


2016-04-13Conversion
2016-04-157:05 pm
N/AN/A
First Data Corp
FDC
Viking Global Investors LpViking Global Performance LLCViking Global Equities LpViking Global Equities II LpVge III Portfolio Ltd.Viking Long Fund Gp LLCViking Long Fund Master Ltd.Halvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
5,413,702
$0
21,750,064(Direct)
View


2016-04-13Conversion
2016-04-157:05 pm
N/AN/A
First Data Corp
FDC
Viking Global Investors LpViking Global Performance LLCViking Global Equities LpViking Global Equities II LpVge III Portfolio Ltd.Viking Long Fund Gp LLCViking Long Fund Master Ltd.Halvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
317,519
$0
21,750,064(Direct)
View


2016-04-13Conversion
2016-04-157:05 pm
N/AN/A
First Data Corp
FDC
Viking Global Investors LpViking Global Performance LLCViking Global Equities LpViking Global Equities II LpVge III Portfolio Ltd.Viking Long Fund Gp LLCViking Long Fund Master Ltd.Halvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
10,144,738
$0
21,750,064(Direct)
View


2016-04-13Conversion
2016-04-157:05 pm
N/AN/A
First Data Corp
FDC
Viking Global Investors LpViking Global Performance LLCViking Global Equities LpViking Global Equities II LpVge III Portfolio Ltd.Viking Long Fund Gp LLCViking Long Fund Master Ltd.Halvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
5,874,105
$0
21,750,064(Direct)
View


2016-02-08Conversion
2016-02-095:59 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.Other
1,709,401
$0
2,729,808(Indirect)
View


2016-02-08Conversion
2016-02-095:59 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.Other
1,709,401
$0
2,729,808(Direct)
View


2016-02-08Conversion
2016-02-095:59 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.Other
4,444,444
$0
2,729,808(Indirect)
View


2016-02-08Conversion
2016-02-095:59 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.Other
4,444,444
$0
2,729,808(Direct)
View


2016-02-08Conversion
2016-02-089:45 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
1,709,401
$0
2,729,808(Indirect)
View


2016-02-08Conversion
2016-02-089:45 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
1,709,401
$0
2,729,808(Direct)
View


2016-02-08Conversion
2016-02-089:45 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
4,444,444
$0
2,729,808(Indirect)
View


2016-02-08Conversion
2016-02-089:45 pm
N/AN/A
Editas Medicine Inc.
EDIT
Viking Global Investors LpViking Global Opportunities Illiquid Investments Sub-master LpViking Global Opportunities Portfolio Gp LLCViking Global Opportunities Gp LLCHalvorsen Ole AndreasOtt David C.Sundheim Daniel S.10% Owner
4,444,444
$0
2,729,808(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 23:35:39 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  








        13D Filing: Viking Global and Axovant Sciences Ltd (AXON) - Insider Monkey                                     
        Companies 0 See All     Hedge Funds 0 See All    Insiders 0 See All    Institutional Investors 0 See All   Click here to see all  results for  Sorry, no results has been found matching your query.                   Adblocker Detected    Dear Valued Visitor, We have noticed that you are using an ad blocker software.
    Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. To view this article, you can disable your ad blocker and refresh this page or simply login. We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.    
   Hedge Funds  13D Filing: Viking Global and Axovant Sciences Ltd (AXON)    Published on June 15, 2017 at 1:53 pm by  
                                Insider Monkey Staff
                                  in Hedge Funds         Page 1 of 17Next &gt&gt          You can access the original SEC filing by clicking here. Ownership Summary Table   Name   Sole Voting Power   Shared Voting Power   Sole Dispositive Power   Shared Dispositive Power   Aggregate Amount Owned Power   Percent of Class    Viking Global Investors   0   0   0   75,000,000   75,000,000   69.8%  Viking Global Performance   0   0   0   75,000,000   75,000,000   69.8%  Viking Global Equities   0   0   0   75,000,000   75,000,000   69.8%  Viking Global Equities II   0   0   0   75,000,000   75,000,000   69.8%  VGE III Portfolio Ltd   0   0   0   75,000,000   75,000,000   69.8%  Viking Long Fund GP   0   0   0   75,000,000   75,000,000   69.8%  Viking Long Fund Master Ltd   0   0   0   75,000,000   75,000,000   69.8%  Viking Global Opportunities GP   0   0   0   75,000,000   75,000,000   69.8%  Viking Global Opportunities Portfolio GP   0   0   0   75,000,000   75,000,000   69.8%  Viking Global Opportunities Illiquid Investments Sub-Master   0   0   0   75,000,000   75,000,000   69.8%  O. Andreas Halvorsen   0   0   0   75,000,000   75,000,000   69.8%  David C. Ott   0   0   0   75,000,000   75,000,000   69.8%  Daniel S. Sundheim   0   0   0   0   0   0.0%   Andreas HalvorsenViking Global        Page 1 of 17 – SEC Filing  SECURITIES AND EXCHANGE COMMISSIONWASHINGTON, DC 20549 SCHEDULE 13D(Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 1*    Axovant Sciences Ltd.   (Name of Issuer)      Common Shares, $0.00001 par value    (Title of Class of Securities)      G0750W104   (CUSIP Number)       Eric Komitee General Counsel 55 Railroad Avenue Greenwich, Connecticut 06830 203-863-5062     (Name,
Address and Telephone Number of Person Authorized
to Receive Notices and Communications)       June 12, 2017   (Date of Event which Requires Filing of this Statement)    If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e),
240.13d-1(f) or 240.13d-1(g), check the following box. ☐ Note.
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7
for other parties to whom copies are to be sent. (Continued on following pages) (Page 1 of 16 Pages) ______________________ * The remainder of this cover page shall be filled
out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this
cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).           Follow Axovant Sciences Ltd.Follow Axovant Sciences Ltd.       Trade (AXON) Now!        Page 1 of 17Next &gt&gt       Related Insider Monkey Articles13D Filing: Lone Star Value Management and Superior Drilling Products Inc. (...13D Filing: Red Mountain Capital and Destination Xl Group Inc. (DXLG)13D Filing: Cannell Capital and Rightside Group Ltd. (NAME)13D Filing: Biotechnology Value Fund LP and CTI Biopharma Corp (CTIC)13D Filing: Marcato Capital Management and Buffalo Wild Wings Inc (BWLD)13D Filing: Discovery Group I, LLC and Aerohive Networks Inc (HIVE) Axovant Sciences Ltd (AXON) Hedge Fund:31 NYSE:AXON SEC 13D Filing Viking Global                Insider Monkey Small Cap Strategy      Download a free copy of our newsletter and see the details inside!     Hedge Fund Resource Center    How to Beat the Market by 20 Percentage Points Why Track Hedge Funds? Download a Free Edition! Why You Should DUMP Your Hedge Funds 6 Things You Didn't Know About Hedge Funds      Billionaire Hedge Funds          Warren Buffett Berkshire Hathaway $147,985,198,000          David Einhorn Greenlight Capital $5,818,885,000          George Soros Soros Fund Management $4,321,285,000          T Boone Pickens BP Capital $318,631,000          Jim Simons Renaissance Technologies $63,208,016,000          Leon Cooperman Omega Advisors $2,269,539,000          Carl Icahn Icahn Capital LP $22,373,522,000          Steve Cohen Point72 Asset Management $14,303,015,000          John Paulson Paulson & Co $7,934,312,000          David Tepper Appaloosa Management LP $5,640,040,000           About Us Contact Us Terms Of Use Privacy Policy       Next Post

   Home Hedge Funds Markets Blog Authors About Us Contact Us Privacy Policy Terms of Use Site Map  All text and design is copyright ©2016 Koala Guide LLC. All rights reserved.            



        13D Filing: Viking Global and Arbutus Biopharma Corp (ABUS) - Insider Monkey                                     
        Companies 0 See All     Hedge Funds 0 See All    Insiders 0 See All    Institutional Investors 0 See All   Click here to see all  results for  Sorry, no results has been found matching your query.                   Adblocker Detected    Dear Valued Visitor, We have noticed that you are using an ad blocker software.
    Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. To view this article, you can disable your ad blocker and refresh this page or simply login. We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.    
   Hedge Funds  13D Filing: Viking Global and Arbutus Biopharma Corp (ABUS)    Published on June 15, 2017 at 2:02 pm by  
                                Insider Monkey Staff
                                  in Hedge Funds         Page 1 of 17Next &gt&gt          You can access the original SEC filing by clicking here. Ownership Summary Table   Name   Sole Voting Power   Shared Voting Power   Sole Dispositive Power   Shared Dispositive Power   Aggregate Amount Owned Power   Percent of Class    Viking Global Investors   0   0   0   16,013,540   16,013,540   29.1%  Viking Global Performance   0   0   0   16,013,540   16,013,540   29.1%  Viking Global Equities   0   0   0   16,013,540   16,013,540   29.1%  Viking Global Equities II   0   0   0   16,013,540   16,013,540   29.1%  VGE III Portfolio Ltd   0   0   0   16,013,540   16,013,540   29.1%  Viking Long Fund GP   0   0   0   16,013,540   16,013,540   29.1%  Viking Long Fund Master Ltd   0   0   0   16,013,540   16,013,540   29.1%  Viking Global Opportunities GP   0   0   0   16,013,540   16,013,540   29.1%  Viking Global Opportunities Portfolio GP   0   0   0   16,013,540   16,013,540   29.1%  Viking Global Opportunities Illiquid Investments Sub-Master   0   0   0   16,013,540   16,013,540   29.1%  O. Andreas Halvorsen   0   0   0   16,013,540   16,013,540   29.1%  David C. Ott   0   0   0   16,013,540   16,013,540   29.1%  Daniel S. Sundheim   0   0   0   0   0   0.0%   Andreas HalvorsenViking Global        Page 1 of 17 – SEC Filing  SECURITIES AND EXCHANGE COMMISSIONWASHINGTON, DC 20549 SCHEDULE 13D(Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 1*    Arbutus Biopharma Corporation   (Name of Issuer)      Common Shares, no par value    (Title of Class of Securities)      03879J100   (CUSIP Number)       Eric Komitee General Counsel 55 Railroad Avenue Greenwich, Connecticut 06830 203-863-5062     (Name,
Address and Telephone Number of Person Authorized
to Receive Notices and Communications)       June 12, 2017   (Date of Event which Requires Filing of this Statement)    If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e),
240.13d-1(f) or 240.13d-1(g), check the following box. ☐ Note.
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7
for other parties to whom copies are to be sent. (Continued on following pages) (Page 1 of 16 Pages) ______________________ * The remainder of this cover page shall be filled
out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this
cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).           Follow Arbutus Biopharma Corp (NASDAQ:ABUS)Follow Arbutus Biopharma Corp (NASDAQ:ABUS)       Trade (NASDAQ:ABUS) Now!        Page 1 of 17Next &gt&gt       Related Insider Monkey Articles13D Filing: Marcato Capital Management and Buffalo Wild Wings Inc (BWLD)13D Filing: Biotechnology Value Fund LP and CTI Biopharma Corp (CTIC)13D Filing: Lone Star Value Management and Superior Drilling Products Inc. (...13D Filing: Cannell Capital and Rightside Group Ltd. (NAME)13D Filing: Red Mountain Capital and Destination Xl Group Inc. (DXLG)13D Filing: Discovery Group I, LLC and Aerohive Networks Inc (HIVE) Arbutus Biopharma Corp (ABUS) Hedge Fund:31 NASDAQ:ABUS SEC 13D Filing Viking Global                Insider Monkey Small Cap Strategy      Download a free copy of our newsletter and see the details inside!     Hedge Fund Resource Center    How to Beat the Market by 20 Percentage Points Why Track Hedge Funds? Download a Free Edition! Why You Should DUMP Your Hedge Funds 6 Things You Didn't Know About Hedge Funds      Billionaire Hedge Funds          Warren Buffett Berkshire Hathaway $147,985,198,000          David Einhorn Greenlight Capital $5,818,885,000          George Soros Soros Fund Management $4,321,285,000          T Boone Pickens BP Capital $318,631,000          Jim Simons Renaissance Technologies $63,208,016,000          Leon Cooperman Omega Advisors $2,269,539,000          Carl Icahn Icahn Capital LP $22,373,522,000          Steve Cohen Point72 Asset Management $14,303,015,000          John Paulson Paulson & Co $7,934,312,000          David Tepper Appaloosa Management LP $5,640,040,000           About Us Contact Us Terms Of Use Privacy Policy       Next Post

   Home Hedge Funds Markets Blog Authors About Us Contact Us Privacy Policy Terms of Use Site Map  All text and design is copyright ©2016 Koala Guide LLC. All rights reserved.            






Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft











Viking Global Opportunities Portfolio GP LLC - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Viking Global Opportunities Portfolio GP LLC
Check out list of companies and businesses related to Viking Global Opportunities Portfolio GP LLC. Find out Viking Global Opportunities Portfolio GP LLC address and contact details. View other people related to Viking Global Opportunities Portfolio GP LLC - coworkers, colleagues, companions, etc.
Address:   

55 RAILROAD AVENUE  GREENWICH 06830 CT




Companies related to Viking Global Opportunities Portfolio GP LLC
CIKCompany NamePositionCompany Address0001447028Arbutus Biopharma Corp100-8900 GLENLYON PARKWAY  BURNABY V5J 5J80001636050Axovant Sciences Ltd.20-22 BEDFORD ROW  LONDON WC1R 4JS0001650664Editas Medicine, Inc.11 HURLEY ST.  CAMBRIDGE 021410001679082Myovant Sciences Ltd.20-22 BEDFORD ROW  LONDON WC1R 4JS




Viking Global Opportunities Portfolio GP LLC on the Web
Persons related to Viking Global Opportunities Portfolio GP LLC - Arbutus Biopharma CorpNamePositionCityMichael J.  AbramsManaging Director BURNABYPaul A.  BrennanBURNABYDANIEL D  BURGESSDirector SAN DIEGOHERBERT J  CONRADDirector MIDDLETONBruce  CousinsEVP & Chief Financial Officer BURNABYDexxon Holdings Ltd.OR AKIVAJEWELL  DONALDBURNABYARTHUR  BRUSKIN  DR.BURNABYIAN  MACLACHLAN  DR.BURNABYMARK  MURRAY  DR.BURNABYMICHAEL  ABRAMS  DR.BURNABYDiane  GardinerBURNABYFRASHIER  GARYBURNABYOLE ANDREAS  HALVORSENGREENWICHRICHARD C  HENRIQUES JRDirector WHITEHOUSE STATIONRICHARD C  HENRIQUES JRBURNABYPatrick T.  HigginsBURNABYElizabeth  HowardExec. VP & General Counsel BURNABYMORTIMER  IANBURNABYHUDSON  JAMESBURNABYDonald Gordon  JewellBURNABYFRANK  KARBEDirector SOUTH SAN FRANCISCOFRANK  KARBEBURNABYDANIEL L  KISNERSAN DIEGODANIEL L  KISNERBURNABYMark  KowalskiSr VP & Chief Medical Officer BURNABYAndrew  LoHAMILTONPeter  LutwycheChief Technology Officer BURNABYClarence Patrick  MachadoSAN FRANCISCOKEITH S  MANCHESTERDirector FORREST  MICHAELBURNABYMark J.  MurrayPresident & CEO BURNABYDan  OrenOR AKIVADavid C.  OttGREENWICHPeggy V  PhillipsBERKELEYPeggy V  PhillipsBURNABYQVT Associates GP LLCNEW YORKQVT Fund V LPNEW YORKIAN  LENNOX  R.BURNABYVivek  RamaswamyDirector BURNABYRoivant Sciences Ltd.HAMILTONRose Sharon  ShabetGREENWICHMichael J.  SofiaChief Scientific Officer BURNABYDaniel S.  SundheimGREENWICHWilliam T.  SymondsChief Development Officer BURNABYVGE III Portfolio Ltd.GREENWICHViking Global Equities II LPGREENWICHViking Global Equities LPGREENWICHVIKING GLOBAL INVESTORS LPGREENWICHViking Global Opportunities GP LLCGREENWICHViking Global Opportunities Illiquid Investments Sub-Master LPGREENWICHVIKING GLOBAL PERFORMANCE LLCGREENWICHViking Long Fund GP LLCGREENWICHViking Long Fund Master Ltd.GREENWICHPersons related to Viking Global Opportunities Portfolio GP LLC - Axovant Sciences Ltd.NamePositionCityMichael  AdasczikPrincipal Accounting Officer NEW YORKMark  AltmeyerPres (ASG) & Chief Comm. Ofc. NEW YORKChristine Mikail  CvijicChief Admin Officer and GC SEATTLEDexxon Holdings Ltd.OR AKIVAKATHRYN E  FALBERGDirector ROCKVILLELAWRENCE MD PHD  FRIEDHOFFChief Development Officer NEW YORKOLE ANDREAS  HALVORSENGREENWICHDavid  HungPrincipal Executive Officer SAN FRANCISCOAndrew  LoHAMILTONClarence Patrick  MachadoDirector SAN FRANCISCOMarion  McCourtPrincipal Operating Officer SAN FRANCISCOBerndt  ModigDirector NEW YORKStephen Frederick  MohrGeneral Counsel NEW YORKLAWRENCE S  OLANOFFDirector NEW YORKDan  OrenOR AKIVAIlan  OrenNEW YORKDavid C.  OttGREENWICHAtul  PandeDirector NEW YORKGary P.  PisanoDirector NEW YORKQVT Associates GP LLCNEW YORKQVT Fund V LPNEW YORKVivek  RamaswamyPrincipal Executive Officer BURNABYAlan S.  RoemerNEW YORKRoivant Sciences Ltd.HAMILTONMarianne L.  RomeoHead,Global Trans & Risk Mgmt HAMILTONRose Sharon  ShabetGREENWICHDaniel S.  SundheimGREENWICHW ANTHONY  VERNONDirector SAN FRANCISCOVGE III Portfolio Ltd.GREENWICHViking Global Equities II LPGREENWICHViking Global Equities LPGREENWICHVIKING GLOBAL INVESTORS LPGREENWICHViking Global Opportunities GP LLCGREENWICHViking Global Opportunities Illiquid Investments Sub-Master LPGREENWICHVIKING GLOBAL PERFORMANCE LLCGREENWICHViking Long Fund GP LLCGREENWICHViking Long Fund Master Ltd.GREENWICHGregory M  WeinhoffPrincipal Financial Officer STAMFORDPersons related to Viking Global Opportunities Portfolio GP LLC - Editas Medicine, Inc.NamePositionCityNOUBAR  AFEYANLEXINGTONCharles  AlbrightChief Scientific Officer CAMBRIDGEGlucksmann  AlexandraCambridgeBorisy  AlexisCambrigeHack  AndrewCambridgeKevin  BittermanDirector WALTHAMbng0, LLC10% Owner SEATTLENikolic  BorisCambridgeAlexis  BorisyDirector BOSTONKatrine  BosleyPresident and CEO CAMBRIDGEGEORGE  CHURCHST. LOUISDouglas G.  ColeDirector CAMBRIDGEGerald Frank  CoxChief Medical Officer CAMBRIDGEDeerfield Healthcare Innovations Fund, L.P.NEW YORKMANAGEMENT CO /NY  DEERFIELDMgmt HIF, L.P  DeerfieldNEW YORKDeerfield Mgmt III, L.P.NEW YORKDeerfield Private Design Fund III, L.P.NEW YORKCole  DouglasCambridgFlagship Ventures Fund IV General Partner LLCCAMBRIDGEFlagship Ventures Fund IV, L.P.10% Owner CAMBRIDGEFlagship Ventures Fund IV-Rx, L.P.CAMBRIDGEJames E  Flynn10% Owner NEW YORKAlexandra  GlucksmannChief Operating Officer CAMBRIDGEAndrew A. F.  HackChief Financial Officer CAMBRIDGEOLE ANDREAS  HALVORSENGREENWICHAndrew  HirschDirector CAMBRIDGEJ. Keith  JoungCAMBRIDGEEDWIN M  KANIA JRCAMBRIDGEBosley  KatrineCambridgeBitterman  KevinCambridgeMARK J  LEVINCAMBRIDGEDavid R.  LiuCAMBRIDGEJOHN  MENDLEINDirector TORONTO CANADA M5J2H2Boris  NikolicDirector CAMBRIDGEDavid C.  OttGREENWICHPolaris Venture Management Co. VI, L.L.C.10% Owner WALTHAMPolaris Venture Partners Founders' Fund VI, L.P.WALTHAMPolaris Venture Partners VI, L.P.WALTHAMKEVIN P  STARR10% Owner CAMBRIDGEDaniel S.  SundheimGREENWICHROBERT I  TEPPERCAMBRIDGEThird Rock Ventures GP III, L.P.BOSTONThird Rock Ventures III, L.P.10% Owner BOSTONTRV GP III, LLCBOSTONAkshay  VaishnawDirector CAMBRIDGEVGE III Portfolio Ltd.GREENWICHMyer  VicCambridgeViking Global Equities II LPGREENWICHViking Global Equities LPGREENWICHVIKING GLOBAL INVESTORS LP10% Owner GREENWICHViking Global Opportunities GP LLCGREENWICHViking Global Opportunities Illiquid Investments Sub-Master LPGREENWICHVIKING GLOBAL PERFORMANCE LLC10% Owner GREENWICHViking Long Fund GP LLCGREENWICHViking Long Fund Master Ltd.GREENWICHFeng  ZhangCAMBRIDGEPersons related to Viking Global Opportunities Portfolio GP LLC - Myovant Sciences Ltd.NamePositionCityMark  AltmeyerDirector NEW YORKTerrie  CurranDirector NEW YORKWayne S  DeVeydtDirector INDIANAPOLISDexxon Holdings Ltd.OR AKIVAOLE ANDREAS  HALVORSENGREENWICHFRANK  KARBESOUTH SAN FRANCISCOMatthew  LangGeneral Counsel & Corp. Secy. BRISBANEAndrew  LoHAMILTONClarence Patrick  MachadoSAN FRANCISCOKEITH S  MANCHESTERDan  OrenOR AKIVADavid C.  OttGREENWICHQVT Associates GP LLCNEW YORKQVT Fund V LPNEW YORKVivek  RamaswamyBURNABYRoivant Sciences Ltd.HAMILTONMarianne L.  RomeoHAMILTONKathleen  SebeliusDirector MENLO PARKLynn  SeelyPrincipal Executive Officer SAN FRANCISCORose Sharon  ShabetGREENWICHDaniel S.  SundheimGREENWICHPharmaceuticals International AG  Takeda10% Owner ZURICHVGE III Portfolio Ltd.GREENWICHViking Global Equities II LPGREENWICHViking Global Equities LPGREENWICHVIKING GLOBAL INVESTORS LPGREENWICHViking Global Opportunities GP LLCGREENWICHViking Global Opportunities Illiquid Investments Sub-Master LPGREENWICHVIKING GLOBAL PERFORMANCE LLCGREENWICHViking Long Fund GP LLCGREENWICHViking Long Fund Master Ltd.GREENWICH












 








Viking Global Equities II LP - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Viking Global Equities II LP
Check out list of companies and businesses related to Viking Global Equities II LP. Find out Viking Global Equities II LP address and contact details. View other people related to Viking Global Equities II LP - coworkers, colleagues, companions, etc.
Address:   

55 RAILROAD AVENUE  GREENWICH 06830 CT




Companies related to Viking Global Equities II LP
CIKCompany NamePositionCompany Address0000883980FIRST DATA CORP225 LIBERTY STREET 29TH FLOOR NEW YORK 102810001447028Arbutus Biopharma Corp100-8900 GLENLYON PARKWAY  BURNABY V5J 5J80001616707Wayfair Inc.4 COPLEY PLACE 7TH FLOOR BOSTON 021160001636050Axovant Sciences Ltd.20-22 BEDFORD ROW  LONDON WC1R 4JS0001650664Editas Medicine, Inc.11 HURLEY ST.  CAMBRIDGE 021410001679082Myovant Sciences Ltd.20-22 BEDFORD ROW  LONDON WC1R 4JS




Viking Global Equities II LP on the Web
Persons related to Viking Global Equities II LP - FIRST DATA CORPNamePositionCityCynthia A  Armine-KleinSee remarks NEW YORKDavid P  BailisSr. EVP OMAHAGUY A  BATTISTAExecutive Vice President ENGLEWOODSCOTT H  BETTSExecutive Vice President GREENWOOD VILLAGEJeffrey R  BillatChief Accounting Officer GREENWOOD VILLAGEFrank  BisignanoChief Executive Officer NEW YORKPeter  BoucherExecutive Vice President GREENWOOD VILLAGEDANIEL P  BURNHAMDirector SANTA BARBARAMatthew  CagwinSee remarks NEW YORKDaniel J  CharronSee remarks NEW YORKGuy  ChiarelloPresident NEW YORKLEON G  COOPERMAN10% Owner ROSELANDDAVID A  COULTERDirector NEW YORKAMBROSE MICHAEL  DExecutive Vice President DECATURSanjiv  DasNEW YORKALISON  DAVISDirector EMERYVEILLCASTRO HENRIQUE  DEDirector SUNNYVALEDavid  DibbleEVP & Chief Technology Officer SUNNYVALEIvo M  DistelbrinkSee remarks NEW YORKHENRY C  DUQUESChief Executive Officer Peter B  EllwoodDirector GREENWOOD VILLAGEJOE W  FOREHANDDirector IRVINGChristopher M  FoskettSee remarks JERSEY CITYCHARLES T  FOTEDirector GREENWOOD VILLAGEAndrew  GelbSee remarks NEW YORKCHRISTINA A  GOLDSr. EVP ENGLEWOODJACK M  GREENBERGDirector Jeffrey I  HackSee remarks NEW YORKOLE ANDREAS  HALVORSENGREENWICHThomas Joseph  HigginsSee remarks NEW YORKCOURTNEY F  JONESDirector RICHARD P  KIPHARTDirector CHICAGOKKR 2006 Fund L.P.NEW YORKKKR 2006 GP LLCNEW YORKKKR Associates 2006 LPNEW YORKKKR & Co. L.P.NEW YORKKKR Fund Holdings GP LtdNEW YORKKKR Fund Holdings L.P.NEW YORKKKR Group Holdings L.P.NEW YORKKKR Group LtdNEW YORKKKR Management LLCNEW YORKHENRY R  KRAVISDirector NEW YORKEDWARD A  LABRY IIISr. EVP MEMHISChristine E  LarsenSee remarks NEW YORKGustavo  MarinSee remarks NEW YORKAnthony S  MarinoSee remarks NEW YORKBarry C  McCarthySee remarks NEW YORKHEIDI  MILLERDirector CHICAGODavid R  MoneyEVP, General Counsel & Sec'y GREENWOOD VILLAGETHOMAS L  MOOREController & CAO GREENWOOD VILLAGEMichael K  NeborakSee remarks NEW YORKJames E  NevelsDirector PHILADELPHIANew Omaha Holdings L.P.NEW YORKNew Omaha Holdings LLCNEW YORKSCOTT C  NUTTALLDirector Tagar  OlsonDirector DALLASDavid C.  OttGREENWICHHimanshu A.  PatelSee remarks NEW YORKKIMBERLY S  PATMOREExecutive Vice President & CFO GREENWOOD VILLAGEPAMELA H  PATSLEYSR. EVP JOSEPH J  PLUMERIDirector NEW YORKGEORGE R  ROBERTSJAMES D  ROBINSON IIIDirector Adam L.  RosmanSee remarks LONDON, ENGLANDCHARLES T  RUSSELLDirector JAMES L  SCHOEDINGERExecutive Vice President OMAHABERNARD L  SCHWARTZDirector NEW YORKJeff  ShanahanExecutive Vice President KING OF PRUSSIAJOAN E  SPERODirector NEW YORKDaniel S.  SundheimGREENWICHWILLIAM DAVID  THOMASSenior Vice President ENGLEWOODDavid  TreinenExecutive Vice President OMAHAVGE III Portfolio Ltd.GREENWICHViking Global Equities LPGREENWICHVIKING GLOBAL INVESTORS LP10% Owner GREENWICHVIKING GLOBAL PERFORMANCE LLCGREENWICHViking Long Fund GP LLCGREENWICHViking Long Fund Master Ltd.GREENWICHARTHUR F  WEINBACHDirector MICHAEL T  WHEALYEVP, Sec & GC OMAHABarbara A.  YastineDirector DULUTHMICHAEL C  YERINGTONSenior Vice President PARSIPPANYPersons related to Viking Global Equities II LP - Arbutus Biopharma CorpNamePositionCityMichael J.  AbramsManaging Director BURNABYPaul A.  BrennanBURNABYDANIEL D  BURGESSDirector SAN DIEGOHERBERT J  CONRADDirector MIDDLETONBruce  CousinsEVP & Chief Financial Officer BURNABYDexxon Holdings Ltd.OR AKIVAJEWELL  DONALDBURNABYARTHUR  BRUSKIN  DR.BURNABYIAN  MACLACHLAN  DR.BURNABYMARK  MURRAY  DR.BURNABYMICHAEL  ABRAMS  DR.BURNABYDiane  GardinerBURNABYFRASHIER  GARYBURNABYOLE ANDREAS  HALVORSENGREENWICHRICHARD C  HENRIQUES JRDirector WHITEHOUSE STATIONRICHARD C  HENRIQUES JRBURNABYPatrick T.  HigginsBURNABYElizabeth  HowardExec. VP & General Counsel BURNABYMORTIMER  IANBURNABYHUDSON  JAMESBURNABYDonald Gordon  JewellBURNABYFRANK  KARBEDirector SOUTH SAN FRANCISCOFRANK  KARBEBURNABYDANIEL L  KISNERSAN DIEGODANIEL L  KISNERBURNABYMark  KowalskiSr VP & Chief Medical Officer BURNABYAndrew  LoHAMILTONPeter  LutwycheChief Technology Officer BURNABYClarence Patrick  MachadoSAN FRANCISCOKEITH S  MANCHESTERDirector FORREST  MICHAELBURNABYMark J.  MurrayPresident & CEO BURNABYDan  OrenOR AKIVADavid C.  OttGREENWICHPeggy V  PhillipsBERKELEYPeggy V  PhillipsBURNABYQVT Associates GP LLCNEW YORKQVT Fund V LPNEW YORKIAN  LENNOX  R.BURNABYVivek  RamaswamyDirector BURNABYRoivant Sciences Ltd.HAMILTONRose Sharon  ShabetGREENWICHMichael J.  SofiaChief Scientific Officer BURNABYDaniel S.  SundheimGREENWICHWilliam T.  SymondsChief Development Officer BURNABYVGE III Portfolio Ltd.GREENWICHViking Global Equities LPGREENWICHVIKING GLOBAL INVESTORS LPGREENWICHViking Global Opportunities GP LLCGREENWICHViking Global Opportunities Illiquid Investments Sub-Master LPGREENWICHViking Global Opportunities Portfolio GP LLCGREENWICHVIKING GLOBAL PERFORMANCE LLCGREENWICHViking Long Fund GP LLCGREENWICHViking Long Fund Master Ltd.GREENWICHPersons related to Viking Global Equities II LP - Wayfair Inc.NamePositionCityNeeraj  AgrawalDirector BOSTONNeeraj  AgrawalBOSTONBattery Investment Partners IX, LLC10% Owner BOSTONBattery Investment Partners IX, LLC10% Owner BOSTONBattery Management Corp.10% Owner BOSTONBattery Management Corp.10% Owner BOSTONBattery Partners IX (AIV I), LLCBOSTONBattery Partners IX, LLCBOSTONBattery Ventures IX (AIV I), L.P.BOSTONJulie MB  BradleyDirector CAMBRIDGEJulie MB  BradleyDirector BOSTONMICHAEL MAURICE  BROWNBOSTONSarah  ConineBOSTONSteven  ConineCo-Founder BOSTONTHOMAS J  CROTTYBOSTONJeremy  DelinskyChief Technology Officer WATERTOWNJesse  FeldmanBOSTONAlex  FinkelsteinDirector BOSTONMICHAEL D  FLEISHERChief Financial Officer STAMFORDMICHAEL D  FLEISHERChief Financial Officer BOSTONRICHARD D  FRISBIEBOSTONCHRISTOPHER S  GAFFNEYBOSTONCHRISTOPHER S  GAFFNEYBOSTONRobert James  GamgortDirector PARSIPPANYRobert James  GamgortPARSIPPANYGHP IV, LLCBOSTONGREAT HILL EQUITY PARTNERS IV LP10% Owner BOSTONGREAT HILL INVESTORS LLCBOSTONGREAT HILL INVESTORS LLCBOSTONGreat Hill Partners GP IV, L.P.BOSTONOLE ANDREAS  HALVORSENGREENWICHHarbourVest IX-Venture Associates L.P.BOSTONHarbourVest IX-Venture Associates LLCBOSTONHARBOURVEST PARTNERS 2007 DIRECT ASSOCIATES L.P. BOSTONHARBOURVEST PARTNERS 2007 DIRECT ASSOCIATES L.P.10% Owner BOSTONHARBOURVEST PARTNERS 2007 DIRECT ASSOCIATES LLCBOSTONHARBOURVEST PARTNERS 2007 DIRECT ASSOCIATES LLCBOSTONHARBOURVEST PARTNERS 2007 DIRECT FUND L.P.BOSTONHARBOURVEST PARTNERS 2007 DIRECT FUND L.P.BOSTONHarbourVest Partners IX-Venture Fund L.P.BOSTONHARBOURVEST PARTNERS LLCBOSTONHARBOURVEST PARTNERS LLCBOSTONHARBOURVEST PARTNERS LLCBOSTONHarbourVest Partners/NYSTRS Co-Investment Fund L.P.BOSTONHarbourVest Partners/NYSTRS Co-Investment Fund L.P.BOSTONHARBOURVEST PARTNERS VIII-VENTURE ASSOCIATES L.P.BOSTONHARBOURVEST PARTNERS VIII-VENTURE ASSOCIATES L.P.BOSTONHARBOURVEST PARTNERS VIII-VENTURE ASSOCIATES LLCBOSTONHARBOURVEST PARTNERS VIII-VENTURE ASSOCIATES LLCBOSTONHarbourVest Partners VIII-Venture Fund L.P.10% Owner BOSTONHarbourVest Partners VIII-Venture Fund L.P.BOSTONJOHN G  HAYESBOSTONJOHN G  HAYESBOSTONHIPEP VI Select Associates L.P.BOSTONHIPEP VI Select Associates L.P.BOSTONHIPEP VI Select Associates LLCBOSTONHIPEP VI Select Associates LLCBOSTONMichael Andrew  KuminDirector BOSTONMichael Andrew  KuminDirector BOSTONIan  LaneBOSTONKENNETH P  LAWLERBOSTONRoger H  LeeBOSTONEdmond  MacriChief Product/Marketing BOSTONNicholas  MaloneChief Administrative Officer BOSTONJames R.  MillerDirector PHOENIXJohn Champlin  MullikenChief Technology Officer BOSTONSteve  OblakSVP and GM, Wayfair.com BOSTONDavid C.  OttGREENWICHThomas W.  Purcell JRGREENWICHRomero  RodriguesDirector BOSTONJames  SavareseChief Operating Officer BOSTONNikunj  ShahBOSTONNiraj  ShahChief Executive Officer BOSTONSpark Capital Founders' Fund III, L.P.BOSTONSpark Capital III (AIV I), L.P.10% Owner BOSTONDaniel S.  SundheimGREENWICHMark D.  TaberBOSTONMark D.  TaberBOSTONR DAVID  TABORSBOSTONR DAVID  TABORSBOSTONSCOTT R  TOBINBOSTONMatthew T  VettelBOSTONMatthew T  VettelBOSTONVGE III Portfolio Ltd.GREENWICHViking Global Equities LPGREENWICHVIKING GLOBAL INVESTORS LP10% Owner GREENWICHVIKING GLOBAL PERFORMANCE LLC10% Owner GREENWICHViking Long Fund GP LLCGREENWICHViking Long Fund Master Ltd.GREENWICHPersons related to Viking Global Equities II LP - Axovant Sciences Ltd.NamePositionCityMichael  AdasczikPrincipal Accounting Officer NEW YORKMark  AltmeyerPres (ASG) & Chief Comm. Ofc. NEW YORKChristine Mikail  CvijicChief Admin Officer and GC SEATTLEDexxon Holdings Ltd.OR AKIVAKATHRYN E  FALBERGDirector ROCKVILLELAWRENCE MD PHD  FRIEDHOFFChief Development Officer NEW YORKOLE ANDREAS  HALVORSENGREENWICHDavid  HungPrincipal Executive Officer SAN FRANCISCOAndrew  LoHAMILTONClarence Patrick  MachadoDirector SAN FRANCISCOMarion  McCourtPrincipal Operating Officer SAN FRANCISCOBerndt  ModigDirector NEW YORKStephen Frederick  MohrGeneral Counsel NEW YORKLAWRENCE S  OLANOFFDirector NEW YORKDan  OrenOR AKIVAIlan  OrenNEW YORKDavid C.  OttGREENWICHAtul  PandeDirector NEW YORKGary P.  PisanoDirector NEW YORKQVT Associates GP LLCNEW YORKQVT Fund V LPNEW YORKVivek  RamaswamyPrincipal Executive Officer BURNABYAlan S.  RoemerNEW YORKRoivant Sciences Ltd.HAMILTONMarianne L.  RomeoHead,Global Trans & Risk Mgmt HAMILTONRose Sharon  ShabetGREENWICHDaniel S.  SundheimGREENWICHW ANTHONY  VERNONDirector SAN FRANCISCOVGE III Portfolio Ltd.GREENWICHViking Global Equities LPGREENWICHVIKING GLOBAL INVESTORS LPGREENWICHViking Global Opportunities GP LLCGREENWICHViking Global Opportunities Illiquid Investments Sub-Master LPGREENWICHViking Global Opportunities Portfolio GP LLCGREENWICHVIKING GLOBAL PERFORMANCE LLCGREENWICHViking Long Fund GP LLCGREENWICHViking Long Fund Master Ltd.GREENWICHGregory M  WeinhoffPrincipal Financial Officer STAMFORDPersons related to Viking Global Equities II LP - Editas Medicine, Inc.NamePositionCityNOUBAR  AFEYANLEXINGTONCharles  AlbrightChief Scientific Officer CAMBRIDGEGlucksmann  AlexandraCambridgeBorisy  AlexisCambrigeHack  AndrewCambridgeKevin  BittermanDirector WALTHAMbng0, LLC10% Owner SEATTLENikolic  BorisCambridgeAlexis  BorisyDirector BOSTONKatrine  BosleyPresident and CEO CAMBRIDGEGEORGE  CHURCHST. LOUISDouglas G.  ColeDirector CAMBRIDGEGerald Frank  CoxChief Medical Officer CAMBRIDGEDeerfield Healthcare Innovations Fund, L.P.NEW YORKMANAGEMENT CO /NY  DEERFIELDMgmt HIF, L.P  DeerfieldNEW YORKDeerfield Mgmt III, L.P.NEW YORKDeerfield Private Design Fund III, L.P.NEW YORKCole  DouglasCambridgFlagship Ventures Fund IV General Partner LLCCAMBRIDGEFlagship Ventures Fund IV, L.P.10% Owner CAMBRIDGEFlagship Ventures Fund IV-Rx, L.P.CAMBRIDGEJames E  Flynn10% Owner NEW YORKAlexandra  GlucksmannChief Operating Officer CAMBRIDGEAndrew A. F.  HackChief Financial Officer CAMBRIDGEOLE ANDREAS  HALVORSENGREENWICHAndrew  HirschDirector CAMBRIDGEJ. Keith  JoungCAMBRIDGEEDWIN M  KANIA JRCAMBRIDGEBosley  KatrineCambridgeBitterman  KevinCambridgeMARK J  LEVINCAMBRIDGEDavid R.  LiuCAMBRIDGEJOHN  MENDLEINDirector TORONTO CANADA M5J2H2Boris  NikolicDirector CAMBRIDGEDavid C.  OttGREENWICHPolaris Venture Management Co. VI, L.L.C.10% Owner WALTHAMPolaris Venture Partners Founders' Fund VI, L.P.WALTHAMPolaris Venture Partners VI, L.P.WALTHAMKEVIN P  STARR10% Owner CAMBRIDGEDaniel S.  SundheimGREENWICHROBERT I  TEPPERCAMBRIDGEThird Rock Ventures GP III, L.P.BOSTONThird Rock Ventures III, L.P.10% Owner BOSTONTRV GP III, LLCBOSTONAkshay  VaishnawDirector CAMBRIDGEVGE III Portfolio Ltd.GREENWICHMyer  VicCambridgeViking Global Equities LPGREENWICHVIKING GLOBAL INVESTORS LP10% Owner GREENWICHViking Global Opportunities GP LLCGREENWICHViking Global Opportunities Illiquid Investments Sub-Master LPGREENWICHViking Global Opportunities Portfolio GP LLCGREENWICHVIKING GLOBAL PERFORMANCE LLC10% Owner GREENWICHViking Long Fund GP LLCGREENWICHViking Long Fund Master Ltd.GREENWICHFeng  ZhangCAMBRIDGEPersons related to Viking Global Equities II LP - Myovant Sciences Ltd.NamePositionCityMark  AltmeyerDirector NEW YORKTerrie  CurranDirector NEW YORKWayne S  DeVeydtDirector INDIANAPOLISDexxon Holdings Ltd.OR AKIVAOLE ANDREAS  HALVORSENGREENWICHFRANK  KARBESOUTH SAN FRANCISCOMatthew  LangGeneral Counsel & Corp. Secy. BRISBANEAndrew  LoHAMILTONClarence Patrick  MachadoSAN FRANCISCOKEITH S  MANCHESTERDan  OrenOR AKIVADavid C.  OttGREENWICHQVT Associates GP LLCNEW YORKQVT Fund V LPNEW YORKVivek  RamaswamyBURNABYRoivant Sciences Ltd.HAMILTONMarianne L.  RomeoHAMILTONKathleen  SebeliusDirector MENLO PARKLynn  SeelyPrincipal Executive Officer SAN FRANCISCORose Sharon  ShabetGREENWICHDaniel S.  SundheimGREENWICHPharmaceuticals International AG  Takeda10% Owner ZURICHVGE III Portfolio Ltd.GREENWICHViking Global Equities LPGREENWICHVIKING GLOBAL INVESTORS LPGREENWICHViking Global Opportunities GP LLCGREENWICHViking Global Opportunities Illiquid Investments Sub-Master LPGREENWICHViking Global Opportunities Portfolio GP LLCGREENWICHVIKING GLOBAL PERFORMANCE LLCGREENWICHViking Long Fund GP LLCGREENWICHViking Long Fund Master Ltd.GREENWICH












 









Welcome to Viking Advocator System®















Dan Taub (Associate General Counsel) logged in





  Chat online or call our 24/7 support on +1-877-566-9574












Invoice Review
Invoice Status Desktop
Monthly Allocation Percentages


















Invoice Review
Invoice Status Desktop
Monthly Allocation Percentages
Support / Help







Invoice Options

Invoice Review

	Add current page to favorites 

My Favorites

Invoice Review










HomeInvoice Review




Invoice Review


















              
                                              Law Firm:                    
                                     
               
                                             Schulte Roth & Zabel, LLP     
                                                  




              
                                              Firm Invoice Date :                
                                         
               
                                             12Jun16                           
                            

           
                                                 Firm Invoice Number :           
                                              
            
                                                DJE 382700                            
                             

           
                                                 Total Invoice :           
                                              
            
                                                13,397.46                             
                             

           
                                                 Currency :           
                                              
            
                                                USD                            
                             






Timekeepers Time Summary                         





Timekeeper Code
Timekeeper Name
                                                                      
                
 
                                             Hours                     
                      
 
                                             Rate             
                              
 
                                             Cost           
                               

 
                                             DE                         
   D. Efron

   7.2

  $1,145.00

   $8,224.00


 
                                             DSG                       
                    
  D.S. Griffel

    0.8    

$850.00    

$680.00



 
                        TW                           
T. Wong   

4.5   

$695.00   

$3,127.50


 
                                             CK                         
  C. Klein   

3.0   

$310.00    

$930.00


 
                        MS                          
  M. Soffley  

   0.2 

   $275.00

   $55.0


EX 
 
Expenses 

                              
                                         
                              
                                         
$360.96

                              
                                         


                              
                                         
Total 
                                                                             
                   
15.7

                             
                                         
$13,397.46                             
                                         
                              
                                         










 Manco Summary                         






 Items
Sum of Total




 Funds     
  $10,376.50 



 
                                             Audit	                        
                    
 $1,488.50 



 
                       Bank debt trading	                         
$1,717.50 



 
                                             Blue Sky filings	  
                        
  $278.00   



 
                        Board Matters	  
     
  $55.00  



 
                        Broken Deal Fees	  
	  
     
  $310.00  



 
                        Compliance general advice	 
	  
     
  $4,007.50   



 
                        Compliance training	  
	  
     
  $1,390.00  



 
                        Directors' regulatory filings 	  
  
	  
     
  $425.00  



 
                        Fund documents	  
  
	  
     
  $310.00  



 
                        General advice	  
	  
	  
     
  $310.00  



 
                        Outsourced contract negotiations	  
	  
	  
     
  $85.00  




VGHK	 
  $1,030.50  



 
                        Employee training	  
	  
	  
	  
     
  $1,030.50  




VGI	  
  $517.50    


 
                        ERISA matters	     
  $347.50  



 
                        General advice	       
  $170.00  




VGIE	
  $1,112.00   


 
                       Derivatives advice - general	      
  $1,112.00   




Expense Alloc. based on Manco/Funds	 
  $360.96   


 
                       General advice	  
  $360.96   




Grand Total 
  $13,397.46   








Wire Log Details









CSFB Payee
Invoice Date
Invoice
CSFB Amount
Currency


Schulte Roth & Zabel, LLP
12Jun16
DJE 382700
$13,397.46 














Expense Type
Legal Bill Categorization
Description
V1 %
V3 %
V2 %
VLFM %
VGOL %
VGOPF %
CORP %
 V1
V3
V2
VLFM
 
VGOL
CORP












 
 
 
 
 
 
 












on behalf of
PE Investment
 TOTAL 
 Export




  $13,397.46 
   










 

          
                  Fees & Disbursements             









Search



By

Select
Entity list Primary
Entity list Secondary
Legal Category
If deal, initial invest. or ongoing exp
VGO Fund Expense Allocation
If deal, name of company
Notes



Search
Reset


Apply your category settings to all the below lines? Yes

Show Allocations

Use the Filter feature above each column to display only your required lines.
 Click the ‘Reset’ link to display all lines.
 To sort by column click on an underlined column heading.

Fees







                        Date

Timekeeper 
                        

Description

Hours
Code
Rate
Total Cost
Entity list Primary*
Entity list Secondary*
Legal Category*
If deal, initial invest. or ongoing exp
VGO Fund Expense Allocation
If deal, name of company
Notes
Post-Review Amount
Make a Reduction


01Dec16
 
  D.Efron
 


                        Tics client re: MVI cha nges; review files; ole DG (DT)
                        

 
1.30
DE
1,145.00
1,488.50


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
Viking_Global_Investors_Europe_LLP
VGI_Europe_Mgmt_Ltd
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited
Viking Global Investors, LP
Viking_Global_Investors_LP_401k
Viking_Global_Investors_Trust
Viking_Global_Opportunities_GP_LLC
Viking_Global_Partners_LLC
Viking_Global_Performance_LLC
Viking_Long_Fund_GP_LLC
Viking_MVI_II_LLC
Viking_MVI_III_LP
Viking_MVI_LLC
Viking_Partners_Fund_III_LP
Viking_Partners_Fund_LP
Viking_Partners_Long_Fund_LP
VCM
Viking_Global_Hong_Kong_Limited
VLF_LP
VLF_Int
VLF3


Select


Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited


Select
Viking_Global_Investors_Europe_LLP
VGI_Europe_Mgmt_Ltd


Select
Viking Global Investors, LP
Viking_Global_Investors_LP_401k
Viking_Global_Investors_Trust
Viking_Global_Opportunities_GP_LLC
Viking_Global_Partners_LLC
Viking_Global_Performance_LLC
Viking_Long_Fund_GP_LLC
Viking_MVI_II_LLC
Viking_MVI_III_LP
Viking_MVI_LLC
Viking_Partners_Fund_III_LP
Viking_Partners_Fund_LP
Viking_Partners_Long_Fund_LP


Select
VCM


Select
Viking_Global_Hong_Kong_Limited


Select
VLF_LP
VLF_Int
VLF3




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage








 
                        
$1,400.00
View Line Item Reduction Details	



Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














15May16		
 
D. Efron		
 


                        MVI changes; review documents; ole TW (DT)
                        
 
1.50 	
DE	 
1,145.00 		 
1,717.50 		


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














04Mar16				
 
 
 


                        Attention to agreements (DT)
                        

 
0.40 	
TW	 
695.00 		  		 
278.00 		


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














05Apr16		
 
C. Klein		
 


                        Updated Form D's for MVI III LP, MY I II LLC, and MYI LLC, no new filings needed, sent email to client (ML)
                        

 
1.00 	
CK	 
310.00 		 
310.00 		


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














06May16		
 
M. Soffley		
 


                        Organization of prior Blue Sky filings for
Viking MY II LLC (ML)
                        

 
0.20 	
MS	 
275.00 		 
55.00 		


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














07Jul16		
 
T. Wong		
 


                        Attention to MY!docs (DT)
                        

 
1.60 	
TW	 
695.00 		 
1,112.00 		


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














12Aug16		
 
D. Efron		
 


                        Review and markup MY!Agreement  and MYI LLCA; o/c T. Wong re: comments; tic's client; ole D. Griffe! (DT)
                        

 
3.50 	
DE	 
1,145.00 		 
4,007.50 		


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














12Sep16		
 
T. Wong		
 


                       Attention to LPA (DT)
                        

 
2.00 	
TW	 
695.00 		 
1,390.00 		


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














13Sep16		
 
D.S. Griffel		
 


                       Review revised agreement and LPA (DT)
                        

 
0.50 	
DSG	 
850.00 		 
425.00 		


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














14Oct16		
 
D. Efron		
 


                       Review revisions to MY1 agreements; ole D. Griffe!re:  tax issues; ole TW (DT)
                        

 
0.90 	
DE	 
1,145.00 		 
1,030.50 		


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














14Oct16		
 
D.S. Griffel		
 


                       Review agreement (DT)
                        

 
0.20 	
DSG	 
850.00 		 
170.00 		


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














14Oct16		
 
T. Wong		
 


                       Attention to LLCA (DT)
                        

 
0.50 	
TW	 
695.00 		 
347.50 


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














15Oct16		
 
D.S. Griffel		
 


                       Review rider (DT)
                        

 
0.10 	
DSG	 
850.00 		 
85.00 		


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














15Oct16		
 
C. Klein		
 


                       Sent email to client re: Form D SEC annual amendments and due date, drafted rorm  DIA' s for MY!I, & li LCC and MVf III LP, sen t to doc svcs to be Edgarized (ML)
                        

 
1.00 	
CK	 
310.00 		 
310.00 		


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation





Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP














22Oct16		
 
C. Klein		
 


                        Proofed and revised Form D SEC annual amendmen ts for MYI I LLC, MCI II LLC and MVI III LP, sent to client for review and signature (ML)
                       

 
1.00 	
CK	 
310.00 		 
310.00 


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation





Select
Ongoing
Initial Exp.




Select
Liquid Sharing Percentage
Estimated Account Balance
Illiquid Participation Percentage









                         
             


Click here






V1%
V3%
V2%
VLFM%
VGOL%
VGOPF%
CORP%











V1
V3
V2
VLFM
VGOL
VGOPF
CORP
















Disbursements






                        Date
Code
Total Cost
Entity list Primary*
Entity list Secondary*

Legal Category
If deal, initial invest. or ongoing exp
Notes
Post-Review Amount
Make a Reduction

30Oct16
EX
$360.96


Select
ALL_Funds_(incl._VGOP)
All_Funds_No VGOP
V1
V2
V3
VGE/VGOL
VGE/VLF
VGE_Only
VGHK
VGI
VGIE
VGOL
Viking_Foundation
VLFM
See Notes
Expense




Select
VGOM
VGOP
VGO1
VGO Int.
VGO3
DRAGGS_8_LLC
DRAGSA_1_LLC
DRAGSA_10_LLC
DRAGSA_11_LLC
DRAGSA_12_LLC
DRAGSA_13_LLC
DRAGSA_14_LLC
DRAGSA_15_LLC
DRAGSA_16_LLC
DRAGSA_17_LLC
DRAGSA_18_LLC
DRAGSA_19_LLC
DRAGSA_2_LLC
DRAGSA_3_LLC
DRAGSA_4_LLC
DRAGSA_5_LLC
DRAGSA_6_LLC
DRAGSA_7_LLC
DRAGSA_9_LLC
DRAGSA_HK_Equities_I_Limited
DRAGSA_HK_Equities_II_Limited
DRAGSA_HK_Equities_III_Limited
DRAGSA_HK_Long_Limited
DRAGSA_HK_Opportunities_Illiquid_Limited
DRAGSA_HK_Opportunities_Liquid_Limited




Select
401(k) plan
Audit
Bank debt trading
Blue Sky filings
Board Matters
Broken Deal Fees
Cayman general advice
Compliance general advice
Compliance training
CTRIP/Qunar
Derivatives advice - general
Directors' regulatory filings 
Disclosure questions
Employee training
Employment law advice
ERISA matters
Filing Advice: Man Co
Flexjet / Net Jets
Fund documents
General advice
Hong Kong general advice
Immigration law advice
Internal review - fund trading
Internal reviews - PRIVILEGED
Investment Advisory Council
Investment research-related advice: long
Investment research-related advice: short
Investment structuring advice
IP advice (trademark, copyright, patent)
Lehman bankruptcy claim
Management company agreements and structuring
MVI
Natural Gas Side Fund
Non-US marketing advice: offshore only
OCIE preparedness
Outsourced contract negotiations
Outsourced forensic testing
Pay-to-play and lobbying advice
Porsche litigation
Private equity investment
QFII application
Real estate and construction
Restricted list analysis
San Francisco office launch
Search firm
Simmons Navigator
Subpoenas and document requests
Tax advice
Trading agreement negotiations
Trading and filing advice - long
Trading and filing advice - short
Trading compliance
Training (non-compliance)
UK general advice
US marketing/private placement advice: all funds
VGO Capital Trademark Dispute
VGO/New Fund
Viking Global Foundation




Select
Ongoing
Initial Exp.





 
                        
                      

Click here







Taxes





Tax 
                        Point Date
Line 
                        Item Type
Taxable 
                        Amount
Tax 
                        Percentage
Tax 
                        Line Item Description
Unit
Rate
Amount 

12Jun16
F
0.00
0.00
No tax due on fees
   
                                                 0.00                         

   
                                                 0.00                         

   
                                                 0.00                         
                    

12Jun16
D
0.00
0.00
No tax due on disbursements
0.00
   
                                                 0.00                         

0.00


Total





Fees
	Expense
Tax
Total


$13,036.50
$360.96	
0.00
 $13,397.46










                
            Use this box to reduce Fees by a single amount:                
          
Forward to… :




              
              
Use this box to reduce Disbursements by a single amount:

Please 
            enter numeric value 

Select Recipient :

Select Recipient
Eric Komitee
Dan Taub


Comments to Law Firm:




                
            
Total of Line Item Fees Reduced on this Screen:
 Please enter numeric value

Comment to Recipient :







Total of Line Item Disbursements Reduced on this Screen:
 Please enter numeric value

Comments to Law Firm:






Total Reduced:



 
 



Total Invoice Discount:  By Percentage


or by Amount
 




Save Draft Copy

Send to Accounting Team for Review
Approve


Submit
                             

















Powered by LSG's Advocator System®, including all copyright and intellectual property rights conveyed therein.
Release No. 0.0.0.0








Close







Close






Contact Support





Offering you 7 Ways to get Help.



Help Documents



Support videos 



FAQs



Chat with us – Mon-Sat 24 Hr



Create a Ticket – An Advocator Expert will contact you within one working day



Request a Call Back Mon-Sat 24 Hr



Call our 24/7 support on 1-877-566-9574











Line Item Reduction




Line Item under review :
Tics client re: MVI changes; review files; ole DG(DT)


Units (Hours) :
 1.30


Amount :
$1,488.50


Reduce Units? :






Reduce Units To :
  
Please enter numeric value
 





Reduce Amount To :



Please enter numeric value
 





Reduce Amount? :


Adjusted Fee Line Amount:
 



Reason for Reduction* :


Please select the reason for reduction
A Junior Attorney should have been used for this activity.
Billed under wrong reference
Blocked billing
Excessive intra-office conferences
Firm overhead expense
Inappropriate charges

No prior approval
No work product defined
Reduction has been made due to previous partial payment
Research time was excessive
Secretarial/Clerical/Administrative/other Non-Billable activity
The activity was not approved
The disbursement was not approved
The fees and expenses incurred to date exceeded the previously submitted budget amount.  Have the handling attorney submit an updated budget
The requested budget was not submitted.  Please submit the budget
The Time Keeper was not authorized to work in this matter
The time spent was excessive
Travel was not approved
Unauthorized work.
Vague description of the services provided

Please select Reason for Reduction



Reduction Comments :










 
                          





























                    View Line Item Reduction Details
                





                            Original Units :
                        

1.30




                            Original Amount :
                        

$1,488.50




                            Adjusted Units :
                        

0.00




                            Adjusted Amount :
                        

$1,400.00




                            Reason for Reduction :
                        

A Junior Attorney should have been used for this activity.





                            Reduction Comments :
                        


                             
                        









































VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC
                    

•   GREENWICH, CT
                      
How do I update this listing?




                                             Viking Global Opportunities Portfolio GP is based out of Greenwich.   
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




viking global opportunities portfolio gp llc


55 RAILROAD AVENUE

GREENWICH
CT
                                                        
                                                    06830


                                                      Business Phone:
                                                      203-863-5000







Recent SEC Filings




3 filed on 10/26/2016
3 filed on 07/13/2016
3 filed on 07/13/2016
4/A filed on 02/09/2016
4 filed on 02/08/2016
3 filed on 02/02/2016
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free

















